Russia looks into its citizen’s removal from domestic US flightWorld July 26, 3:43
US House of Representatives passes bill to toughen sanctions on RussiaWorld July 26, 1:09
Diplomat blasts US media reports on Russia's alleged arms supplies to TalibanRussian Politics & Diplomacy July 25, 21:39
Putin, Iraqi vice-president discuss possible supplies of T-90 tanksMilitary & Defense July 25, 21:18
Sports minister hopes for Russia’s membership reinstatement with IAAF before 2018Sport July 25, 20:47
The highlights of 2017 FINA World ChampionshipsSport July 25, 19:37
IAAF to hear report on Russia’s reinstatement ahead of 2017 Athletics World ChampionshipSport July 25, 19:25
EU Council to discuss Nord Stream 2 project in SeptemberBusiness & Economy July 25, 19:13
Berlin preparing common European response to Siemens turbines supplies to Crimea — sourceBusiness & Economy July 25, 18:49
From skin tightening with Thermage ® to skin resurfacing with Fraxel ® and Clear + Brilliant ™ to acne treatment with Isolaz ® and CLARO ™ to the newest non-invasive fat reduction device Liposonix ® , Solta Medical's leading aesthetic energy device portfolio treats millions of patients worldwide
HAYWARD, Calif., April 4, 2012 /PRNewswire/ -- Solta Medical, Inc. (Nasdaq: SLTM), the pioneer in fractional resurfacing and non-invasive skin tightening and a global market leader in aesthetic treatments, introduced the second generation Liposonix system, its new non-invasive fat reduction device using high intensity focused ultrasound (HIFU), at the 10th Anti-aging Medicine World Congress (AMWC) in Monaco. Clinical studies have demonstrated an average waist circumference reduction of approximately 2.6 cm (1 inch) after a single Liposonix treatment.
The company also announced that more than two million procedures have been completed around the world using its portfolio of leading aesthetic energy device (AED) products. This industry milestone reflects significant advances made over the past decade, starting with the introduction of Thermage's radiofrequency skin tightening technology system in 2002 and its most recent evolution incorporates proprietary Comfort Pulse Technology™ that delivers more therapeutic heat across the treatment area, allowing for a more efficient skin tightening treatment. Thermage was followed in 2004 by Fraxel, a revolutionary fractional laser treatment to resurface the skin and address sun damage and unwanted pigmentation. In 2007, the Isolaz acne fighting system using a gentle vacuum to purify pores and intense pulsed light to kill bacteria was launched. An at-home companion device to Isolaz, CLARO began selling at retail outlets in 2010. More recently, Clear + Brilliant a new, less-invasive approach to laser skin enhancement to prevent the unwanted signs of aging was developed utilizing Fraxel technology, and finally, this year Liposonix.
"Over the years, Solta has helped transform aesthetic medicine - with its deep roots in rigorous science by providing gold-standard energy technologies used to treat patients who sought effective and safe skin treatments," said Roy G. Geronemus, MD, Clinical Professor of Dermatology at New York University Medical Center and Director of the Laser & Skin Surgery Center of New York. "Solta products have been go-to treatment solutions for my patients looking for non-invasive options for everything from skin resurfacing and tightening to preventative and maintenance care to slow down the aging process to clearing acne and now fat reduction. I have been using Solta's entire line of aesthetic energy devices not only because patients ask for them by name but also because the products deliver their promised results time after time."
"More than two million treatments worldwide is an important milestone for Solta Medical. With this achievement, we continue to demonstrate our leadership position in the market through the growing acceptance of our brand portfolio around the globe," said Stephen J. Fanning, Chairman of the Board, president and CEO of Solta Medical, Inc. "We are continually investing in R&D and looking to introduce new, safe, innovative devices that deliver the best possible results for physicians and their patients in more than 100 markets around the world."
For more information on Solta Medical, visit www.Solta.com.
About SOLTA MEDICAL, INC.
Solta Medical, Inc. is a global leader in the medical aesthetics market providing innovative, safe, and effective solutions for patients that enhance and expand the practice of medical aesthetics for physicians. The company offers six aesthetic energy devices to address a range of issues, including skin resurfacing and rejuvenation with Fraxel® and Clear + Brilliant™, body contouring and skin tightening with Liposonix® and Thermage® and acne reduction with Isolaz® and CLARO™. As the innovator and leader in fractional laser technology, Fraxel delivers minimally invasive clinical solutions to resurface aging and sun damaged skin. Using the same fractional laser technology, Clear + Brilliant is a unique, cost-effective treatment to correct and prevent early signs of aging. For body contouring, Liposonix is a non-surgical treatment to reduce waist circumference with advanced high-intensity focused ultrasound (HIFU) technology to permanently destroy targeted fat beneath the skin. Thermage is an innovative, non-invasive radiofrequency procedure for tightening and contouring skin. Isolaz was the first laser or light based system indicated for the treatment of inflammatory acne, comedonal acne, pustular acne, and mild-to-moderate inflammatory acne. CLARO is a personal care acne system that is the first FDA cleared over-the-counter IPL device that uses a powerful combination of both heat and light to clear skin quickly and naturally. More than two million procedures have been performed with Solta Medical's portfolio of products around the world.
For more information about Solta Medical, call 1-877-782-2286 or log on to www.Solta.com.
© 2012 Solta Medical, Inc. All rights reserved. Thermage, Fraxel, Isolaz, Clear + Brilliant, CLARO, Liposonix and Solta Medical are trademarks or registered trademarks of Solta Medical, Inc. or its subsidiaries.
Solta Medical, Inc.
Jennifer Hacker, COHN & WOLFE